FI933193A0 - Behandling av neoplastisk sjukdom med interleukin-10 - Google Patents

Behandling av neoplastisk sjukdom med interleukin-10

Info

Publication number
FI933193A0
FI933193A0 FI933193A FI933193A FI933193A0 FI 933193 A0 FI933193 A0 FI 933193A0 FI 933193 A FI933193 A FI 933193A FI 933193 A FI933193 A FI 933193A FI 933193 A0 FI933193 A0 FI 933193A0
Authority
FI
Finland
Prior art keywords
interleukin
sjukdom
neoplastisk
behandling
med
Prior art date
Application number
FI933193A
Other languages
English (en)
Other versions
FI933193A (fi
Inventor
Paulo J M Vieira
Kevin W Moore
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI933193A0 publication Critical patent/FI933193A0/fi
Publication of FI933193A publication Critical patent/FI933193A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI933193A 1991-01-16 1993-07-14 Behandling av neoplastisk sjukdom med interleukin-10 FI933193A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64134791A 1991-01-16 1991-01-16
PCT/US1992/000066 WO1992012725A1 (en) 1991-01-16 1992-01-15 Treatment of neoplastic disease with interleukin-10

Publications (2)

Publication Number Publication Date
FI933193A0 true FI933193A0 (fi) 1993-07-14
FI933193A FI933193A (fi) 1993-07-14

Family

ID=24571976

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933193A FI933193A (fi) 1991-01-16 1993-07-14 Behandling av neoplastisk sjukdom med interleukin-10

Country Status (18)

Country Link
EP (1) EP0567576B1 (fi)
JP (1) JP3260368B2 (fi)
KR (1) KR100207766B1 (fi)
AT (1) ATE116550T1 (fi)
AU (1) AU652030B2 (fi)
CA (1) CA2100553A1 (fi)
CZ (1) CZ282523B6 (fi)
DE (1) DE69201128T2 (fi)
DK (1) DK0567576T3 (fi)
ES (1) ES2068705T3 (fi)
FI (1) FI933193A (fi)
GR (1) GR3015510T3 (fi)
HK (1) HK192196A (fi)
HU (1) HU218598B (fi)
NO (1) NO310444B1 (fi)
OA (1) OA09908A (fi)
SK (1) SK279556B6 (fi)
WO (1) WO1992012725A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106823A (en) 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
DE4122402A1 (de) * 1991-07-04 1993-01-07 Schering Ag Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
IL106725A (en) * 1992-08-20 2000-12-06 Schering Plough Corp Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
EP0740552A1 (en) * 1994-01-20 1996-11-06 Schering Corporation Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
WO1996018412A1 (en) 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
WO2001005821A2 (en) * 1999-07-16 2001-01-25 Maria Teresa Bejarano Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis
ES2367891T3 (es) 2000-09-29 2011-11-10 Schering Corporation Interleucina-10 pegilada.
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
DK2379115T3 (da) 2008-12-17 2018-01-29 Merck Sharp & Dohme Fremstilling og anvendelse af mono- og di-PEG-IL-10
CA2908198A1 (en) 2013-04-18 2014-10-23 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
WO2015070060A1 (en) 2013-11-11 2015-05-14 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP2017536098A (ja) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１５組成物及びその使用
US10143726B2 (en) 2014-10-22 2018-12-04 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
AU2016312510A1 (en) 2015-08-25 2018-03-08 Armo Biosciences, Inc. Methods of using Interleukin-10 for treating diseases and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
ZA9010188B (en) * 1989-12-20 1991-08-28 Schering Corp Bcrf1 proteins as inhibitors of interferon-gamma

Also Published As

Publication number Publication date
GR3015510T3 (en) 1995-06-30
NO932570L (no) 1993-07-15
NO310444B1 (no) 2001-07-09
EP0567576B1 (en) 1995-01-04
HUT69962A (en) 1995-09-28
DE69201128D1 (de) 1995-02-16
JP3260368B2 (ja) 2002-02-25
CZ282523B6 (cs) 1997-07-16
JPH06504785A (ja) 1994-06-02
SK74793A3 (en) 1995-03-08
HU218598B (hu) 2000-10-28
HK192196A (en) 1996-10-25
CZ141293A3 (en) 1994-01-19
DK0567576T3 (da) 1995-06-12
OA09908A (en) 1994-09-15
WO1992012725A1 (en) 1992-08-06
NO932570D0 (no) 1993-07-15
CA2100553A1 (en) 1992-07-17
ATE116550T1 (de) 1995-01-15
SK279556B6 (sk) 1998-12-02
AU1261792A (en) 1992-08-27
AU652030B2 (en) 1994-08-11
FI933193A (fi) 1993-07-14
ES2068705T3 (es) 1995-04-16
EP0567576A1 (en) 1993-11-03
HU9302066D0 (en) 1993-11-29
KR100207766B1 (ko) 1999-07-15
DE69201128T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
FI933193A0 (fi) Behandling av neoplastisk sjukdom med interleukin-10
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
AU7044894A (en) (phospho)lipids for combatting hepatitis b virus infection
NO179531C (no) Fremgangsmåte for brönnbehandling
NO914352L (no) Fremgangsmaate for behandling av brukte katodebunner
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
MY104521A (en) Treatment of depression.
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
IT1222182B (it) Macchina per il trattamento terapeutico di lombalgie e lombosciatalgie
NO173145C (no) Fremgangsmaate for behandling av voerter
SE8306384L (sv) Farmaceutisk komposition
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
NO923541D0 (no) Innretning for medisinsk behandling av kroppsdeler
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
NO171565C (no) Fremgangsmaate for behandling av manganslam
BG31970A1 (en) Operative method for medical treating of chronic lympheden of limb
SE8902106D0 (sv) Anordning foer behandling av ryggpatienter
RO94514A2 (ro) Procedeu pentru tratarea namolurilor
NO920694L (no) Fremgangsmaate for etterbehandling av tremasse
BG33452A1 (en) Means for medical treating of intestine infection
NO170493C (no) Fremgangsmaate for hydrogenerende behandling av klorholdige forbindelser
EP0266114A3 (en) Etodolac for inhibition of joint ankylosis